The Yellow Fever Vaccine Journey: Milestones and Future Directions [PDF]
VaccinesYellow fever, a mosquito-borne viral hemorrhagic disease, remains a significant public health concern in endemic regions of Africa and South America. The development of the yellow fever vaccine marked a milestone in virology and immunization.
Shriyansh Srivastava +13 more
doaj +4 more sources
Yellow fever vaccine coverage and associated factors among under-five children in Kenya: Data from Kenyan Demographic and Health Survey 2022 [PDF]
Human Vaccines & ImmunotherapeuticsYellow fever is a vaccine preventable hemorrhagic disease that leads to morbidity and mortality in the affected individuals. The only options for preventing and controlling its spread are through vaccination.
Mohammed Seid Ali, Enyew Getaneh Mekonen
doaj +3 more sources
Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. [PDF]
PLoS ONE, 2008 Implementation of yellow fever vaccination is currently hampered by limited supply of vaccine. An alternative route of administration with reduced amounts of vaccine but without loss of vaccine efficacy would boost vaccination programmes.A randomized ...
Anna H Roukens +4 more
doaj +4 more sources
Safe administration of yellow fever vaccine in patients with suspected egg allergy [PDF]
Journal of Allergy and Clinical Immunology: Global, 2023 Background: The evidence available in the literature on the administration and safety of the yellow fever vaccine in patients with egg allergy is limited.
Fernanda Tormin Tanos Lopes, MSc +4 more
doaj +2 more sources
BMJ, 2002 Three recently published articles, from Brazil, the United States, and Australia, and three follow up letters from Europe, have challenged the reputation of the yellow fever vaccine, 17D, that for more than 50 years was almost beyond reproach.1–6 These reports describe an illness resembling yellow fever occurring within a week of vaccination for yellow
Philip P. Mortimer
openaire +5 more sources
Estimating the number of unvaccinated Chinese workers against yellow fever in Angola [PDF]
BMC Infectious Diseases, 2018 Background A yellow fever epidemic occurred in Angola in 2016 with 884 laboratory confirmed cases and 373 deaths. Eleven unvaccinated Chinese nationals working in Angola were also infected and imported the disease to China, thereby presenting the first ...
A. Wilder-Smith, E. Massad
doaj +4 more sources
Serious adverse event: late neurotropic disease associated with yellow fever vaccine [PDF]
Einstein (São Paulo), 2020 The yellow fever is a systemic disease that was under control due to the effective campaigns against the vector and promotion of vaccines programs. However, since 1999, outbreaks appeared because of inefficient control of the vector, and led to the need ...
Henrique Souza Barros de Oliveira +5 more
doaj +3 more sources
Case Report: Yellow Fever Vaccine-Associated Neurotropic Disease and Associated MRI, EEG, and CSF Findings [PDF]
Frontiers in Neurology, 2022 Yellow fever vaccine-associated neurotropic disease (YEL-AND) is a rare and serious complication following vaccination with the 17D live attenuated yellow fever vaccine.
Michelle Cohen +12 more
doaj +2 more sources
Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA. [PDF]
J Travel Med, 2023 Rojas A +4 more
europepmc +3 more sources
Transmission of yellow fever vaccine virus from breast feeding mothers to their infants: reporting of yellow fever virus (YFV) RNA detection in milk specimens [version 4; peer review: 1 approved, 2 approved with reservations] [PDF]
F1000Research, 2022 Background Because of yellow fever’s serious impact on health, vaccination is the principal strategy to control the disease. Administration of the yellow fever vaccine to breastfeeding women should be before they complete 9 months post-delivery, in order
Abdel Rahim M El Hussein +6 more
doaj +2 more sources